Episode Details

Healthcare doesn't need more AI pilots. It needs AI that can prove its value. Healthcare organizations are moving beyond experimenting with individual AI tools and beginning to think about AI as enterprise infrastructure. But scaling AI across an entire health system requires more than adding algorithms. It requires integrated workflows, secure technology infrastructure, clinical validation, data governance, and measurable financial and clinical impact.

In this episode of The Beat's AI at ViVE series, Sandy Vance sits down with Dr. David Stoffel, Chief Business Officer at RapidAI, to discuss how healthcare AI is evolving from point solutions into enterprise platforms. David explains how RapidAI expanded from its roots in stroke care to a broader clinical AI platform, why health systems are looking to consolidate dozens of AI pilots, and what it takes to connect imaging insights to action throughout the patient journey.

The conversation also explores clinical AI, healthcare IT infrastructure, interoperability, AI governance, clinical validation, reimbursement, and ROI. David shares why the next phase of healthcare AI will be defined not simply by what an algorithm can do, but by whether it can produce measurable improvements in clinical care and financial performance.

In this episode, they talk about:

• How RapidAI evolved from a stroke detection tool into an enterprise clinical AI platform
• Why healthcare is shifting from asking "Why AI?" to asking "How?"
• The three major challenges healthcare organizations are looking to AI to solve
• Why clinical impact, workforce capacity, and future-proof IT infrastructure all matter
• The problem with managing dozens or even hundreds of individual AI point solutions
• Why enterprise AI platforms can help connect workflows across departments
• What "deep clinical AI" means and how it can support the patient journey beyond initial disease detection
• How AI can quantify, visualize, localize, and track disease over time
• Why seamless workflow integration is critical to making AI useful in clinical practice
• How hybrid on-premises and cloud infrastructure can improve resilience during cybersecurity incidents
• Why AI governance and performance tracking are essential for turning a tool into an operational solution
• How RapidAI is incorporating third-party algorithms into its platform
• Why clinical validation remains central to successful healthcare AI adoption
• What CIOs should look for when evaluating AI platforms
• How health systems can evaluate clinical ROI and financial ROI
• Why reimbursement can help transform AI from a cost center into a potential profit center
• Why the healthcare AI market may be headed toward consolidation and simplification
• Why measurable clinical and financial value will ultimately separate successful AI companies from the rest

A Little About David:

David Stoffel, M.D., has spent more than 20 years developing and commercializing innovative technologies and services in the medical device industry. David has an extensive track record of success in scaling healthcare businesses. Notably, he led marketing and corporate development at Intuitive Surgical, contributing significantly to establishing the da Vinci surgical robotic system as a new surgical standard of care. He also helped launch and lead the Mobile Cardiac Telemetry business at iRhythm Technologies, one of the fastest-growing digital health companies, and was Chief Business Officer at Ceribell, maker of an innovative point-of-care EEG solution.

Earlier in his career, David was a partner at a healthcare venture capital firm, where he invested in